Answers are grounded in this paper and cite their sources.
Use of the qHPV vaccine reduced the rates of anal intraepithelial neoplasia, including of grade 2 or 3, among men who have sex with men. The vaccine had a favorable safety profile and may help to reduce the risk of anal cancer. (Funded by Merck and the National Institutes of Health; ClinicalTrials.gov number, NCT00090285.).
No takes yet. Share an insight, caveat, or question.
Palefsky et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: